| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |